Cerebrovascular stiffness and flow dynamics in the presence of amyloid and tau biomarkers.

Leonardo Rivera RiveraLaura EisenmengerKarly A CodyThomas ReherTobey BetthauserRobert V CadmanHoward A RowleyCynthia M CarlssonNathaniel A ChinSterling C JohnsonKevin M Johnson

Published in: Alzheimer's & dementia (Amsterdam, Netherlands) (2021)

Cerebrovascular markers indicate increased vessel stiffness and reduced vasomotion in AT biomarker-positive subjects during preclinical AD.

Keyphrases

cerebrospinal fluid
cell therapy
bone marrow
mesenchymal stem cells